Phathom Pharma Inc Live Stock Price Today, Share Analysis and Chart

Name: Phathom Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: Phathom Pharmaceuticals Inc
Rating: 0.98983325
Author: Trendlyne DVM scores

about

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule...

10.09 0.44 (4.56%)

44.89% Fall from 52W High

2.0M

XNAS Volume

XNAS 03 Jun, 2026 5:30 PM (EDT)

Board Meeting

The next board meeting for Phathom Pharma Inc is on 09 Jun 2026 for the purpose of Goldman Sachs 47th Annual Global Healthcare Conference See details

Not Eligible

Expensive Valuation

10.8 / 100

Technically Bearish

28.8 / 100

1Yr Price target upside is 135%

10 analysts

Phathom Pharma Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Phathom Pharma Inc Live Stock Price Today, Share Analysis and Chart

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule...

44.89% Fall from 52W High

SWOT Analysis

Phathom Pharma Inc Live Price Chart